![Gina M. Wallar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Gina M.
Wallar worked as a Director at LabCorp Clinical Trials.
She then worked at NeoGenomics, Inc. as the President-Pharma Services Division from 2021 to 2022.
Dr. Wallar holds a doctorate degree from the University of California, Los Angeles.
Precedenti posizioni note di Gina M. Wallar
| Società | Posizione | Fine |
|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 27/05/2022 |
LabCorp Clinical Trials
 LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Direttore/Membro del Consiglio | - |
Formazione di Gina M. Wallar
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
35
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LabCorp Clinical Trials
LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
